We are live on ! Find out more
PM

Penbrook Management Portfolio holdings

AUM $157M
1-Year Est. Return 46.57%
This Fund
S&P 500
This Quarter Est. Return
-3.05%
1 Year Est. Return
+46.57%
3 Year Est. Return
+102.93%
5 Year Est. Return
+150.44%
10 Year Est. Return
AUM
$154M
AUM Growth
-$11.8M
Cap. Flow
-$36K
Cap. Flow %
-0.02%
Top 10 Hldgs %
42.4%
Holding
114
New
12
Increased
11
Reduced
33
Closed
5

Sector Composition

Rank Sector Weight
1 Technology 23.76%
2 Healthcare 20.89%
3 Energy 11.21%
4 Financials 11.04%
5 Industrials 8.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FISV
76
Fiserv Inc
FISV
$29B
$466K 0.3%
4,591
-2,200
-32% -$223K
BTRS
77
DELISTED
BTRS Holdings Inc. Class 1 Common Stock
BTRS
$460K 0.3%
+61,490
New +$398K
LINC icon
78
Lincoln Educational Services
LINC
$1.37B
$449K 0.29%
+62,805
New +$455K
BBSI icon
79
Barrett Business Services
BBSI
$979M
$442K 0.29%
22,800
COP icon
80
ConocoPhillips
COP
$145B
$412K 0.27%
4,120
OPRX icon
81
OptimizeRx
OPRX
$123M
$399K 0.26%
10,568
+3,493
+49% +$155K
EVT icon
82
Eaton Vance Tax-Advantaged Dividend Income Fund
EVT
$2.13B
$398K 0.26%
13,739
-6,500
-32% -$180K
TWOU
83
DELISTED
2U Inc
TWOU
$367K 0.24%
922
MIN
84
Aberdeen Intermediate Income Fund
MIN
$274M
$357K 0.23%
113,429
-3,000
-3% -$9.9K
MRK icon
85
Merck
MRK
$316B
$353K 0.23%
+4,300
New +$339K
VKQ icon
86
Invesco Municipal Trust
VKQ
$537M
$345K 0.22%
30,000
DIS icon
87
Walt Disney
DIS
$170B
$342K 0.22%
2,490
+375
+18% +$54.2K
WLY icon
88
John Wiley & Sons Class A
WLY
$2.7B
$323K 0.21%
6,100
HBIO icon
89
Harvard Bioscience
HBIO
$28.5M
$311K 0.2%
5,000
SBGI icon
90
Sinclair Inc
SBGI
$1B
$305K 0.2%
10,900
-700
-6% -$19.4K
CVX icon
91
Chevron
CVX
$385B
$293K 0.19%
1,800
DBI icon
92
Designer Brands
DBI
$331M
$281K 0.18%
20,820
ARCC icon
93
Ares Capital
ARCC
$13.8B
$271K 0.18%
12,940
AFL icon
94
Aflac
AFL
$64.5B
$264K 0.17%
4,100
NUV icon
95
Nuveen Municipal Value Fund
NUV
$1.91B
$254K 0.16%
26,500
ITCI
96
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$245K 0.16%
4,000
ET icon
97
Energy Transfer Partners
ET
$69.8B
$231K 0.15%
20,618
DE icon
98
Deere & Co
DE
$163B
$229K 0.15%
+550
New +$211K
IBM icon
99
IBM
IBM
$213B
$222K 0.14%
+1,710
New +$223K
JPS
100
DELISTED
Nuveen Preferred & Income Securities Fund
JPS
$218K 0.14%
+26,000
New +$228K

Similar funds

Penbrook Management's Q1 2022 Portfolio in Review

As of Q1 2022, Penbrook Management held 114 positions worth $154M, down 7.1% from $166M the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Penbrook Management's Q1 2022 filing shows 12 new, 11 increased, 33 reduced and 5 closed positions. Its largest new stake was Telesis Bio, Inc. Common Stock: 8,009 shares worth $774K. The largest sale was Axcelis, an estimated $967K.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 26% a quarter earlier, followed by Healthcare and Energy.

  • Penbrook Management's largest Q1 2022 buy was Telesis Bio, Inc. Common Stock: 8,009 shares worth $774K.
  • Penbrook Management added most to PubMatic in Q1 2022, an estimated $806K increase.
  • Penbrook Management's biggest Q1 2022 reduction was Axcelis, cutting an estimated $967K.
  • Penbrook Management fully exited Nuance Communications, Inc. in Q1 2022, selling an estimated $805K.
  • Penbrook Management's ten largest holdings make up 42% of its $154M portfolio in Q1 2022.
  • Penbrook Management opened 12 new positions and closed 5 in Q1 2022.
  • Penbrook Management's portfolio value fell 7.1% quarter-over-quarter to $154M.

Based on Penbrook Management's 13F filing for Q1 2022, filed 26 Apr 2022.